PRIMEBODY Trademark

Pharmaceutical preparations for the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; therapeutic pharmaceuticals for the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; pharmaceutical preparations, namely, pro drug or drug delivery systems comprising biologics for conditional activation, tissue or tumor targeting; therapeutic and diagnostic agents, preparations, and substances for medical purposes; pharmaceutical preparations and substances for use in the field of oncology, immunology, autoimmune, metabolic, and inflammatory diseases; therapeutic and diagnostic agents and preparations consisting primarily of biochemicals for medical use

Scientific and technological research and development in the fields of pharmaceuticals, biotechnology, and medical diagnostics namely, preparations, biologics, and diagnostic agents; development of drugs for oncology, immunology, autoimmune, metabolic, and inflammatory diseases, conditionally-activated or tumor-activated therapeutics or biologics; providing a scientific and technological platform for research and development of drug candidates; conducting clinical and pre-clinical research in the field of pharmaceuticals and biotechnology; pharmaceutical research, development, and analysis, namely relating to the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; providing scientific information and data relating to pharmaceutical, biotechnological, and clinical research